Fundraising Fox

Cyclarity Therapeutics

Novato, US · Founded 2019 · Delaware corporation

Biotech

Founders & leadership

Cyclarity Therapeutics was founded in 2019 by Matthew O'Connor.

MO
Matthew O'ConnorFounder
MK
Michael KopeNamed on SEC filing
FS
Frank SchuelerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$15.3M disclosed across 3 rounds · 2019–2024

▶$10.3MraisedDec 2024 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew O'ConnorExecutive Officer, Director
  • Michael KopeExecutive Officer, Director
Offering amount
$12.8M
Amount sold
$10.3M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2021 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew O'ConnorExecutive Officer, Director
  • Frank SchuelerDirector
  • Michael KopeExecutive Officer, Director
Offering amount
$10M
Amount sold
$3.5M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedNov 2019 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew O'ConnorExecutive Officer, Director
  • Frank SchuelerDirector
  • Michael KopeExecutive Officer, Director
Offering amount
$4M
Amount sold
$1.5M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Cyclarity Therapeutics?
Cyclarity Therapeutics was founded by Matthew O'Connor in 2019.
How much funding has Cyclarity Therapeutics raised?
Cyclarity Therapeutics has disclosed $15.3M raised across 3 rounds.
Where is Cyclarity Therapeutics headquartered?
Cyclarity Therapeutics is headquartered in Novato, US.